177 related articles for article (PubMed ID: 17245736)
1. Cytokine induction by respiratory syncytial virus and adenovirus in bronchial epithelial cells.
Yoon JS; Kim HH; Lee Y; Lee JS
Pediatr Pulmonol; 2007 Mar; 42(3):277-82. PubMed ID: 17245736
[TBL] [Abstract][Full Text] [Related]
2. Respiratory syncytial virus deficient in soluble G protein induced an increased proinflammatory response in human lung epithelial cells.
Arnold R; König B; Werchau H; König W
Virology; 2004 Dec; 330(2):384-97. PubMed ID: 15567433
[TBL] [Abstract][Full Text] [Related]
3. Cytokine (tumor necrosis factor, IL-6, and IL-8) production by respiratory syncytial virus-infected human alveolar macrophages.
Becker S; Quay J; Soukup J
J Immunol; 1991 Dec; 147(12):4307-12. PubMed ID: 1753101
[TBL] [Abstract][Full Text] [Related]
4. Respiratory syncytial virus-induced RANTES production from human bronchial epithelial cells is dependent on nuclear factor-kappa B nuclear binding and is inhibited by adenovirus-mediated expression of inhibitor of kappa B alpha.
Thomas LH; Friedland JS; Sharland M; Becker S
J Immunol; 1998 Jul; 161(2):1007-16. PubMed ID: 9670982
[TBL] [Abstract][Full Text] [Related]
5. Cytokine amplification by respiratory syncytial virus infection in human nasal epithelial cells.
Das S; Palmer OP; Leight WD; Surowitz JB; Pickles RJ; Randell SH; Buchman CA
Laryngoscope; 2005 May; 115(5):764-8. PubMed ID: 15867636
[TBL] [Abstract][Full Text] [Related]
6. Interleukin (IL)-12 gene transduction and its functional expression into human bronchial epithelial cells (BEAS-2B) by adenovirus vector.
Ogawa H; Nishimura N; Nishioka Y; Azuma M; Yanagawa H; Sone S
J Med Invest; 2002 Feb; 49(1-2):74-82. PubMed ID: 11901765
[TBL] [Abstract][Full Text] [Related]
7. Respiratory syncytial virus infection of human primary nasal and bronchial epithelial cell cultures and bronchoalveolar macrophages.
Becker S; Soukup J; Yankaskas JR
Am J Respir Cell Mol Biol; 1992 Apr; 6(4):369-74. PubMed ID: 1550681
[TBL] [Abstract][Full Text] [Related]
8. Epithelial cells infected with respiratory syncytial virus are resistant to the anti-inflammatory effects of hydrocortisone.
Bonville CA; Mehta PA; Krilov LR; Rosenberg HF; Domachowske JB
Cell Immunol; 2001 Nov; 213(2):134-40. PubMed ID: 11831875
[TBL] [Abstract][Full Text] [Related]
9. RANTES (CCL5) production during primary respiratory syncytial virus infection exacerbates airway disease.
Tekkanat KK; Maassab H; Miller A; Berlin AA; Kunkel SL; Lukacs NW
Eur J Immunol; 2002 Nov; 32(11):3276-84. PubMed ID: 12555673
[TBL] [Abstract][Full Text] [Related]
10. Ozone effect on respiratory syncytial virus infectivity and cytokine production by human alveolar macrophages.
Soukup J; Koren HS; Becker S
Environ Res; 1993 Feb; 60(2):178-86. PubMed ID: 8472647
[TBL] [Abstract][Full Text] [Related]
11. The effect of fluticasone propionate on respiratory syncytial virus-induced chemokine release by a human bronchial epithelial cell line.
Noah TL; Wortman IA; Becker S
Immunopharmacology; 1998 Jun; 39(3):193-9. PubMed ID: 9754905
[TBL] [Abstract][Full Text] [Related]
12. Effect of nitrogen dioxide on respiratory viral infection in airway epithelial cells.
Becker S; Soukup JM
Environ Res; 1999 Aug; 81(2):159-66. PubMed ID: 10433848
[TBL] [Abstract][Full Text] [Related]
13. RSV infection of human airway epithelial cells causes production of the beta-chemokine RANTES.
Becker S; Reed W; Henderson FW; Noah TL
Am J Physiol; 1997 Mar; 272(3 Pt 1):L512-20. PubMed ID: 9124609
[TBL] [Abstract][Full Text] [Related]
14. Primary airway epithelial cultures from children are highly permissive to respiratory syncytial virus infection.
Fonceca AM; Flanagan BF; Trinick R; Smyth RL; McNamara PS
Thorax; 2012 Jan; 67(1):42-8. PubMed ID: 21865207
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in the respiratory tracts of human infants following paramyxovirus infection.
Elliott MB; Welliver RC; Laughlin TS; Pryharski KS; LaPierre NA; Chen T; Souza V; Terio NB; Hancock GE
J Med Virol; 2007 Apr; 79(4):447-56. PubMed ID: 17311330
[TBL] [Abstract][Full Text] [Related]
16. Respiratory syncytial virus induces the expression of 5-lipoxygenase and endothelin-1 in bronchial epithelial cells.
Behera AK; Kumar M; Matsuse H; Lockey RF; Mohapatra SS
Biochem Biophys Res Commun; 1998 Oct; 251(3):704-9. PubMed ID: 9790973
[TBL] [Abstract][Full Text] [Related]
17. Respiratory syncytical virus-induced chemokine expression in the lower airways: eosinophil recruitment and degranulation.
Harrison AM; Bonville CA; Rosenberg HF; Domachowske JB
Am J Respir Crit Care Med; 1999 Jun; 159(6):1918-24. PubMed ID: 10351940
[TBL] [Abstract][Full Text] [Related]
18. The effect of respiratory synctial virus on chemokine release by differentiated airway epithelium.
Mellow TE; Murphy PC; Carson JL; Noah TL; Zhang L; Pickles RJ
Exp Lung Res; 2004; 30(1):43-57. PubMed ID: 14967603
[TBL] [Abstract][Full Text] [Related]
19. Induction of IL-6 and CCL5 (RANTES) in human respiratory epithelial (A549) cells by clinical isolates of respiratory syncytial virus is strain specific.
Levitz R; Wattier R; Phillips P; Solomon A; Lawler J; Lazar I; Weibel C; Kahn JS
Virol J; 2012 Sep; 9():190. PubMed ID: 22962966
[TBL] [Abstract][Full Text] [Related]
20. Bronchial epithelium-derived IL-8 and RANTES increased bronchial smooth muscle cell migration and proliferation by Krüppel-like factor 5 in areca nut-mediated airway remodeling.
Kuo PL; Hsu YL; Huang MS; Chiang SL; Ko YC
Toxicol Sci; 2011 May; 121(1):177-90. PubMed ID: 21297082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
